All In Biotech

Free tool

FAERS Monitor: Acticlate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205931 or its brand name (Acticlate, Doxycycline Hyclate). Reports on generic versions are filed under their own applications.

Reports

17,438

Serious

10,245

59% of reports

Hospitalization

4,803

Death reported

2,363

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity2,303
  • fatigue1,817
  • nausea1,709
  • pain1,489
  • rash1,462
  • off label use1,431
  • drug ineffective1,414
  • headache1,402
  • diarrhoea1,368
  • dyspnoea1,348
  • vomiting1,337
  • pruritus1,165
  • pneumonia1,157
  • dizziness1,114
  • condition aggravated1,094

Reports by year received

View as table
YearReports
200415
200514
200623
200725
200836
200988
2010107
2011142
2012255
2013251
2014341
2015561
20161,057
20171,000
20181,393
20191,665
20201,507
20211,126
20221,186
20231,259
20241,874
20252,120
20261,392

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,721 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug hypersensitivitySignal2,30314.514.028,888
condition aggravatedSignal1,0944.44.12,852
pneumoniaSignal1,1574.34.12,987
rashSignal1,4624.13.93,422
pruritusSignal1,1653.73.52,289
vomitingSignal1,3373.43.32,354
painSignal1,4892.92.81,941
dyspnoeaSignal1,3482.92.71,690
fatigueSignal1,8172.82.72,208
headacheSignal1,4022.72.61,543
dizzinessSignal1,1142.72.51,215
nauseaSignal1,7092.62.51,755
diarrhoeaSignal1,3682.62.41,337
off label use1,4312.01.9714
drug ineffective1,4141.31.2101

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.